Abstract
During a disease outbreak, healthcare workers (HCWs) are essential to treat infected individuals. However, these HCWs are themselves susceptible to contracting the disease. As more HCWs get infected, fewer are available to provide care for others, and the overall quality of care available to infected individuals declines. This depletion of HCWs may contribute to the epidemic’s severity. To examine this issue, we explicitly model declining quality of care in four differential equation-based SIR-type models with vaccination. We assume that vaccination, recovery, and survival rates are affected by quality of care delivered. We show that explicitly modelling healthcare workers and accounting for declining quality of care significantly alters model-predicted disease outcomes, specifically case counts and mortality. Models neglecting the decline of quality of care resulting from infection of HCWs may significantly under-estimate cases and mortality. These models may be useful to inform health policy that may differ for healthcare workers and the general population. Models accounting for declining quality of care may therefore improve the management interventions considered to mitigate the effects of a future outbreak.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We also acknowledge the Applied Math REU 2016 at Penn State and Dean Mary Beth Williams for the funding they provided to IP. Additionally, this work was partially supported by funding from the National Science Foundation RAPIDD Grant DMS-1514704, NIH EEID Award 1 R01 GM105247-01 and NSF COVID-19 RAPID award DEB-2028301 (KS) and by National Science Foundation Grant No. DMS-1714654 and NIH grant 1 R21 AI143443-01A1 (JMC).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
n/a
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
n/a
